Billiontoone (NASDAQ:BLLN) Shares Up 8.2% – Should You Buy?

Billiontoone, Inc. (NASDAQ:BLLN)’s share price shot up 8.2% on Thursday . The company traded as high as $104.50 and last traded at $106.4690. 72,786 shares changed hands during trading, a decline of 82% from the average session volume of 414,616 shares. The stock had previously closed at $98.36.

Analysts Set New Price Targets

BLLN has been the topic of several recent analyst reports. Weiss Ratings raised Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a report on Friday, May 15th. JPMorgan Chase & Co. increased their target price on Billiontoone from $120.00 to $125.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Wells Fargo & Company dropped their target price on Billiontoone from $110.00 to $90.00 and set an “equal weight” rating on the stock in a report on Thursday, March 5th. BTIG Research dropped their target price on Billiontoone from $140.00 to $130.00 and set a “buy” rating on the stock in a report on Thursday, May 7th. Finally, Wall Street Zen raised Billiontoone from a “hold” rating to a “buy” rating in a report on Saturday, March 7th. Six equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $125.29.

Billiontoone Stock Down 7.1%

The stock has a market cap of $4.47 billion and a PE ratio of 176.71. The firm has a fifty day moving average of $85.56 and a 200 day moving average of $88.19. The company has a quick ratio of 10.58, a current ratio of 10.92 and a debt-to-equity ratio of 0.18.

Billiontoone (NASDAQ:BLLN) last posted its earnings results on Wednesday, May 6th. The company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.01 by $0.33. The business had revenue of $108.39 million during the quarter, compared to analysts’ expectations of $95.81 million. The business’s quarterly revenue was up 83.8% compared to the same quarter last year. During the same period last year, the company earned ($0.39) EPS. On average, equities research analysts anticipate that Billiontoone, Inc. will post 0.93 EPS for the current fiscal year.

Hedge Funds Weigh In On Billiontoone

Hedge funds have recently made changes to their positions in the company. Rossby Financial LCC purchased a new position in shares of Billiontoone during the fourth quarter worth about $25,000. Wells Fargo & Company MN purchased a new position in shares of Billiontoone during the fourth quarter worth about $76,000. Smartleaf Asset Management LLC purchased a new position in shares of Billiontoone during the fourth quarter worth about $80,000. Nano Cap New Millennium Growth Fund L P purchased a new position in shares of Billiontoone during the fourth quarter worth about $82,000. Finally, Renaissance Capital LLC purchased a new position in shares of Billiontoone during the fourth quarter worth about $201,000.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.